Granules India Receives Licences from MPP to Market generic of Pfizers Paxlovid MD Bureau21 March 2022 11:46 AM ISTThe product will be made at Granules manufacturing facilities in India that are approved by global regulatory agencies including USFDA. The license...
COVID-19: 35 pharma cos to mass product generic version of Pfizer's Paxlovid MD Bureau18 March 2022 6:16 PM ISTIn India, Hyderabad-based pharma major Aurobindo Pharma has signed the agreement.
Laurus Labs inks pact with MPP to manufacture molnupiravir Medical Dialogues Bureau22 Jan 2022 3:52 PM ISTNew Delhi: Drug firm Laurus Labs on Friday said it has inked a pact with Geneva-based MPP (Medicine Patient Pool) for manufacturing the oral COVID-19...
Biophore India gets MPP licence to market molnupiravir Dr. Divya Colin22 Jan 2022 3:14 PM ISTNew Delhi: Biophore India Pharmaceuticals on Thursday said it has received licences from Medicines Patent Pool (MPP) on behalf of originator company...
